专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

51. 发明申请

US20110181398A1 Method for Adjusting the Transmission Time of a Continuous Wave and Reader Thereof 有权
标题翻译：调整连续波及其阅读器传输时间的方法
公开(公告)号：US20110181398A1
公开(公告)日：2011-07-28
申请号：US13003736
申请日：2010-09-09
申请人： Hui Li , Yong Yuan , Liang Zhang
发明人： Hui Li , Yong Yuan , Liang Zhang
IPC分类号： G06K7/01
CPC分类号： G06K7/0008 , G06K7/10217 , G06K7/10297
摘要： A reader and method for adjusting the transmission time of a continuous wave (CW), wherein the method comprises setting an initial value for a response waiting time, sending the CW to a tag after sending a command to the tag and waiting for a response from the tag, judging whether the response from the tag is received within the response waiting time. If the response from the tag is received within the response waiting time, then sending of the CW is stopped and the response waiting time is adjusted. If the response from the tag is still not received beyond the response waiting time, then sending of the CW is stopped. The time for the reader to wait for a response from the tag is far less than 20 ms. Consequently, a command failure can be found early, so as to improve the processing efficiency of an RFID system.
摘要翻译：一种用于调整连续波（CW）的传输时间的读取器和方法，其中所述方法包括设置响应等待时间的初始值，在向标签发送命令并等待响应之后将CW发送到标签标签，判断在响应等待时间内是否接收到来自标签的响应。如果在响应等待时间内接收到来自标签的响应，则停止发送CW并且调整响应等待时间。如果在响应等待时间之后仍然没有收到标签的响应，则CW的发送被停止。读者等待标签响应的时间远远少于20 ms。因此，可以及早发现命令故障，以提高RFID系统的处理效率。

52. 发明申请

US20110178577A1 METHOD AND APPARATUS FOR OPERATING A DIVERSITY ANTENNA SYSTEM FOR COMMUNICATING WITH IMPLANTABLE MEDICAL DEVICE 有权
标题翻译：用于与可移植医疗设备通信的多样性天线系统的方法和装置
公开(公告)号：US20110178577A1
公开(公告)日：2011-07-21
申请号：US13072922
申请日：2011-03-28
申请人： Hui Li , Joseph E. Bange , Sylvia Quiles , Prashant Rawat , Vineel Vallapureddy
发明人： Hui Li , Joseph E. Bange , Sylvia Quiles , Prashant Rawat , Vineel Vallapureddy
IPC分类号： A61N1/36
CPC分类号： H04L1/24 , A61B5/0031 , A61B5/7203 , A61B5/7221 , A61N1/37223 , A61N1/37252 , H04B7/0608 , H04B7/0814 , Y10S128/903
摘要： A far-field radio frequency (RF) telemetry system for communicating with an implantable medical device includes a diversity antenna system. Multi-frame messages each including multiple outgoing data frames are transmitted to the implantable medical device. In response, the implantable medical device transmits response data frames each following one or more of the outgoing data frames, according to a predetermined communication protocol. An antenna control circuit selects an antenna of the diversity antenna system for transmitting the outgoing data frames and/or receiving the response data frames based the quality of signal reception associated with the response data frames.
摘要翻译：用于与可植入医疗装置通信的远场射频（RF）遥测系统包括分集天线系统。每个包括多个输出数据帧的多帧消息被传送到可植入医疗设备。作为响应，可植入医疗装置根据预定的通信协议发送每个跟随一个或多个输出数据帧的响应数据帧。天线控制电路基于与响应数据帧相关联的信号接收的质量来选择用于发送输出数据帧的分集天线系统的天线和/或接收响应数据帧。

53. 发明申请

US20110144084A1 6 SUBSTITUTED 2- HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS 失效
标题翻译： 6作为CHK-1抑制剂的取代的2-杂环基亚氨基吡嗪化合物
公开(公告)号：US20110144084A1
公开(公告)日：2011-06-16
申请号：US13057558
申请日：2009-08-04
申请人： John Frederick Braganza , Michael Raymond Collins , John Charles Kath , Sacha Ninkovic , Hui Li , Daniel Tyler Richter
发明人： John Frederick Braganza , Michael Raymond Collins , John Charles Kath , Sacha Ninkovic , Hui Li , Daniel Tyler Richter
IPC分类号： A61K31/497 , C07D401/14 , C07D471/04 , C07D487/04 , C07D403/14 , C07D513/04 , A61K31/4985 , A61K31/519 , A61K31/5377 , A61K31/55 , A61P35/00 , A61P17/06 , A61P35/02
CPC分类号： C07D401/14 , C07D403/14 , C07D471/04 , C07D487/04 , C07D513/04 , C07D519/00
摘要： The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as CHK-1 inhibitors.
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，其合成及其作为CHK-1抑制剂的用途。

54. 发明授权

US07919628B2 CXCR2 inhibitors 有权
标题翻译： CXCR2抑制剂
公开(公告)号：US07919628B2
公开(公告)日：2011-04-05
申请号：US11771958
申请日：2007-06-29
申请人： Stephanie Hachtel , Juergen Dedio , Holger Heitsch , Werngard Czechtizky , Sven Grueneberg , Stephen J. Shimshock , Raymond W. Kosley, Jr. , Carolina L. Lanter , Hui Li , Rosy Sher , Aleksandra Weichsel
发明人： Stephanie Hachtel , Juergen Dedio , Holger Heitsch , Werngard Czechtizky , Sven Grueneberg , Stephen J. Shimshock , Raymond W. Kosley, Jr. , Carolina L. Lanter , Hui Li , Rosy Sher , Aleksandra Weichsel
IPC分类号： C07D277/64 , A61K31/426
CPC分类号： C07D213/68 , C07D207/325 , C07D213/30 , C07D213/65 , C07D213/69 , C07D215/14 , C07D217/26 , C07D231/12 , C07D233/64 , C07D249/06 , C07D249/08 , C07D249/18 , C07D261/08 , C07D263/32 , C07D271/12 , C07D277/24 , C07D277/64 , C07D307/42 , C07D317/54 , C07D319/20 , C07D333/56 , C07D333/70 , C07D409/12 , C07D417/12 , C07D495/04
摘要： The invention relates to compounds of the formula I: in which R1, R2, X, A, B, D and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
摘要翻译：本发明涉及式I化合物：其中R1，R2，X，A，B，D和Y1至Y4具有权利要求中所示的含义，和/或其药学上可接受的盐和/或前药。由于其作为趋化因子受体的抑制剂的特性，特别是作为CXCR2抑制剂，式I化合物及其药学上可接受的盐和前药适用于预防和治疗趋化因子介导的疾病。

55. 发明申请

US20110027856A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY 有权
公开(公告)号：US20110027856A1
公开(公告)日：2011-02-03
申请号：US12902052
申请日：2010-10-11
申请人： Hui Li , Vanessa Taylor , Somasekhar Bhamidipati , John Ramphal , Kin Tso , Arvinder Sran , Holger Keim , Vadim Markovtsov , David Carroll , Sambaiah Thota , Ankush Argade , Jeffrey Wayne Clough , Rajinder Singh , Robin Cooper
发明人： Hui Li , Vanessa Taylor , Somasekhar Bhamidipati , John Ramphal , Kin Tso , Arvinder Sran , Holger Keim , Vadim Markovtsov , David Carroll , Sambaiah Thota , Ankush Argade , Jeffrey Wayne Clough , Rajinder Singh , Robin Cooper
IPC分类号： C12N9/99
CPC分类号： A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5383 , C07D239/48 , C07D239/49 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D491/04 , C07D498/04
摘要： The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

56. 发明申请

US20110016005A1 PROVIDING ADVERTISEMENTS FROM RELATED SEARCH QUERIES 审中-公开
标题翻译：从相关搜索查询提供广告
公开(公告)号：US20110016005A1
公开(公告)日：2011-01-20
申请号：US12511752
申请日：2009-07-29
申请人： Hui Li , Yong Zhang , Gangjiang Li , Boon-Lock Yeo
发明人： Hui Li , Yong Zhang , Gangjiang Li , Boon-Lock Yeo
IPC分类号： G06Q30/00
CPC分类号： G06Q30/0256 , G06F16/248 , G06F16/9535 , G06Q30/02 , G06Q30/0251 , G06Q30/0277
摘要： Methods, systems and apparatus for identifying advertisements previously presented when processing related search queries related to a submitted search query, and providing the advertisements identified from the related search queries for presentation on a search results page for the submitted search query.
摘要翻译：用于识别当处理与所提交的搜索查询有关的相关搜索查询时先前呈现的广告的方法，系统和装置，以及提供从相关搜索查询识别的广告，以便在所提交的搜索查询的搜索结果页上呈现。

57. 发明授权

US07834024B2 Compositions and methods for inhibition of the JAK pathway 有权
标题翻译：用于抑制JAK途径的组合物和方法
公开(公告)号：US07834024B2
公开(公告)日：2010-11-16
申请号：US12053438
申请日：2008-03-21
申请人： Hui Li , Vanessa Taylor , Somasekhar Bhamidipati , John Ramphal , Kin Tso , Avinder Sran , Holger Keim , Vadim Markovtsov , David Carroll , Sambaiah Thota , Ankush Argade , Jeffrey Wayne Clough , Rajinder Singh , Robin Cooper
发明人： Hui Li , Vanessa Taylor , Somasekhar Bhamidipati , John Ramphal , Kin Tso , Avinder Sran , Holger Keim , Vadim Markovtsov , David Carroll , Sambaiah Thota , Ankush Argade , Jeffrey Wayne Clough , Rajinder Singh , Robin Cooper
IPC分类号： A61K31/505
CPC分类号： A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5383 , C07D239/48 , C07D239/49 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D491/04 , C07D498/04
摘要： The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
摘要翻译：本发明包括具有式I的化合物和使用这些化合物的组合物和方法用于治疗JAK途径的调节或JAK激酶，特别是JAK3的抑制在治疗上有用的条件。

58. 发明授权

US07825116B2 N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines 有权
标题翻译： N 2，N 4 - 双 - 芳基-5-氟-2,4-嘧啶二亚胺
公开(公告)号：US07825116B2
公开(公告)日：2010-11-02
申请号：US11539101
申请日：2006-10-05
申请人： Rajinder Singh , Ankush Argade , Donald G. Payan , Jeffrey Clough , Holger Keim , Somasekhar Bhamidipati , Catherine Sylvain , Hui Li
发明人： Rajinder Singh , Ankush Argade , Donald G. Payan , Jeffrey Clough , Holger Keim , Somasekhar Bhamidipati , Catherine Sylvain , Hui Li
IPC分类号： C07D239/48 , C07D403/12 , A61K31/506
CPC分类号： A61K31/506 , A61K31/519 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D413/12 , C07D413/14 , C07D471/04 , C07D498/04 , Y10S514/825 , Y10S514/903
摘要： The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
摘要翻译：本发明提供了用2,4-嘧啶二胺化合物治疗或预防自身免疫疾病的方法，以及治疗，预防或改善与这些疾病相关的症状的方法。可以用化合物治疗或预防的自身免疫性疾病的具体实例包括类风湿性关节炎和/或其相关症状，系统性红斑狼疮病和/或其相关症状和多发性硬化症和/或其相关症状。

59. 发明授权

US07812669B2 Predistortion apparatus, system, and method 有权
标题翻译：预失真装置，系统和方法
公开(公告)号：US07812669B2
公开(公告)日：2010-10-12
申请号：US12485456
申请日：2009-06-16
申请人： Hui Li , Zhan Shi , Jianmin Zhou
发明人： Hui Li , Zhan Shi , Jianmin Zhou
IPC分类号： H03F1/26
CPC分类号： H03F1/3247 , H03F2201/3233
摘要： The present invention discloses a predistortion apparatus, a predistortion system and a predistortion method. The predistorter comprises a modular value calculating section, for performing modular arithmetic on an information source input signal inputted from an information source; an orthogonal lookup table value acquiring section, for searching N stored lookup tables orthogonal to one another, finding out corresponding output of each lookup table in accordance with the modular value of the information source input signal, and acquiring N lookup table values, wherein N is an integer greater than 1; a multiplying section, for multiplying the N lookup table values acquired by the orthogonal lookup table value acquiring section with N amplitude adjustment factors to obtain N amplitude adjustment values, and multiplying the N lookup table values with N phase adjustment factors to obtain N phase adjustment values; and a summating section, for summating the N amplitude adjustment values to obtain an amplitude predistortion value, and summating the N phase adjustment values to obtain a phase predistortion value.
摘要翻译：本发明公开了一种预失真装置，预失真系统和预失真方法。预失真器包括模块值计算部分，用于对从信息源输入的信息源输入信号进行模数运算; 正交查找表值获取部分，用于搜索彼此正交的N个存储的查找表，根据信息源输入信号的模块值找出每个查找表的相应输出，并获取N个查找表值，其中N是大于1的整数; 乘法部分，用于将由正交查找表值获取部分获取的N个查找表值与N个幅度调整因子相乘以获得N个幅度调整值，并将N个查找表值与N个相位调整因子相乘以获得N个相位调整值 ; 以及求和部分，用于对N个振幅调整值进行求和以获得幅度预失真值，并且对N个相位调整值进行求和以获得相位预失真值。

60. 发明授权

US07812029B1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds 有权
标题翻译：用2,4-嘧啶二胺化合物治疗或预防自身免疫性疾病的方法
公开(公告)号：US07812029B1
公开(公告)日：2010-10-12
申请号：US12028581
申请日：2008-02-08
申请人： Rajinder Singh , Ankush Argade , Donald G. Payan , Jeffrey Clough , Holger Keim , Somasekhar Bhamidipati , Catherine Sylvain , Hui Li
发明人： Rajinder Singh , Ankush Argade , Donald G. Payan , Jeffrey Clough , Holger Keim , Somasekhar Bhamidipati , Catherine Sylvain , Hui Li
IPC分类号： C07D239/42
CPC分类号： A61K31/506 , A61K31/519 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D413/12 , C07D413/14 , C07D471/04 , C07D498/04 , Y10S514/825 , Y10S514/903
摘要： The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
摘要翻译：本发明提供了用2,4-嘧啶二胺化合物治疗或预防自身免疫疾病的方法，以及治疗，预防或改善与这些疾病相关的症状的方法。可以用化合物治疗或预防的自身免疫性疾病的具体实例包括类风湿性关节炎和/或其相关症状，系统性红斑狼疮病和/或其相关症状和多发性硬化症和/或其相关症状。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式